LIPOPROTEIN LIPASE FOR TREATMENT OF HYPERTRIGLYCERIDEMIC-RELATED CONDITIONS INCLUDING ACUTE PANCREATITIS

A lipoprotein lipase (LPL) protein for treating and/or preventing HTG and its associated diseases, including but not limited to acute pancreatitis (AP), and in particular, acute pancreatitis secondary to or exacerbated by hypertriglyceridemia, and hypertriglyceridemia and its associated diseases in...

Full description

Saved in:
Bibliographic Details
Main Authors TANGARONE, BRUCE, STRACK-LOGUE, BETTINA, GUEY, LIN, VON KRUSENSTIERN, LENORE, DOWIE, TRACY, FRANCONE, OMAR L, LOW, LIEH YOON, TRAYLOR, MATTHEW, LUNDBERG, DIANNA, HOLMES, KEVIN, NORTON, ANGELA, ZHANG, BOHONG, MEIYAPPAN, MUTHURAMAN
Format Patent
LanguageEnglish
French
Published 14.04.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A lipoprotein lipase (LPL) protein for treating and/or preventing HTG and its associated diseases, including but not limited to acute pancreatitis (AP), and in particular, acute pancreatitis secondary to or exacerbated by hypertriglyceridemia, and hypertriglyceridemia and its associated diseases in general, including cardiovascular and metabolic diseases, endocrine disorders, and fat embolism syndrome. La présente invention concerne une protéine lipoprotéine lipase (LPL) pour le traitement et/ou la prévention de la HTG et des maladies associées, y compris, de manière non restrictive, la pancréatite aiguë (AP), et en particulier, la pancréatite aiguë secondaire à ou exacerbée par l'hypertriglycéridémie, et l'hypertriglycéridémie et les maladies généralement associées, y compris des maladies cardio-vasculaires et des maladies métaboliques, les troubles endocriniens, et le syndrome d'embolie graisseuse.
Bibliography:Application Number: WO2015US45921